{"nct_id":"NCT00034281","title":"Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2","status":"COMPLETED","status_verified_date":"2012-01","start_date":"2002-06","start_date_type":null,"primary_completion_date":"2003-09","primary_completion_date_type":"ACTUAL","completion_date":"2003-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}